FindTrial
Sign In

USING INTRAOPERATIVE TOPICAL ANTIBIOTIC INJECTION AROUND THE HEAD END AND THE ABDOMINAL END OF VENTRICULOPERITONEAL SHUNT IN REDUCTION OF SHUNTINFECTION.

ROLE OF INTRAOPERATIVE TOPICAL ANTIBIOTIC INJECTION AROUND THE VENTRICULAR END AND THE PERITONEAL END OF VENTRICULOPERITONEAL SHUNT IN REDUCTION OF SHUNTINFECTION: A RANDOMISED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052735
Enrollment
200
Registered
2023-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G919- Hydrocephalus, unspecified

Interventions

Intervention1: INTRAOPERATIVE TOPICAL ANTIBIOTIC INJECTION AROUND THE VENTRICULAR END AND THE PERITONEAL END OF VENTRICULOPERITONEAL SHUNT: Group A- will receive intraoperative topical antibiotic mixt

Sponsors

Neurosurgery AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of any age with the confirmed diagnosis of hydrocephalus requiring VP shunt placement to improve patientsâ?? neurological outcome. The diagnosis of hydrocephalus will be based on clinical (features of raised ICP, enlarging head and dilated scalp veins in children, papilledema, etc) and radiological indicators of hydrocephalus (dilated ventricles) in CTs and/or MRIs.

Exclusion criteria

Exclusion criteria: ï?· Patients undergoing ventriculoperitoneal shunt revision with a previous history of shunt infection. ï?· Patients with deranged renal function test. ï?· Patients with associated major comorbidities (e.g., congenital anomalies like Tetralogy of Fallot, renal agenesis, etc.) that need prolonged medical or surgical intervention because they may affect neurosurgical outcomes.

Design outcomes

Primary

MeasureTime frame
To study the shunt infection rate post VP shunt insertion in the two groupsTimepoint: During a period of 1 year post procedure.—

Secondary

MeasureTime frame
To study the shunt blockage incidence post VP shunt insertion in the two groupsTimepoint: During a period of 1 year post procedure.—

Countries

India

Contacts

Public ContactPrachi Singh

AIIMS, New Delhi

kanwaljeet@aiims.edu9968569905

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026